Evaluation of Cervical Fusion With DTRAX® Cervical Cage With DTRAX Bone Screw

Cervical Radiculopathy Clinical Trial

Official title:

Evaluation of Cervical Fusion With DTRAX® Cervical Cage With DTRAX Bone Screw in Patients With Cervical Radiculopathy

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02694250
• Other study ID #: DTRAXCCB-001
• Status: Withdrawn
• Phase: N/A
• Start date: November 2015
• Est. completion date: September 2016

Study information

• Verified date: March 2020
• Source: Providence Medical Technology, Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is being conducted to assess the radiographic (x-rays and CT scans) and clinical outcomes for the use of DTRAX Cervical Cage with DTRAX Bone Screw for the treatment of degenerative disc disease at one disc level with accompanying radicular symptoms in the cervical (neck) spine.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: September 2016
• Est. primary completion date: September 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 35 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Subject diagnosed with one level cervical spondylosis with radiculopathy in C3-C7, defined as follows:

a. Radiographically (at least one): i. degenerated disc on MRI and/or CT; ii. decreased disc height on MRI and/or CT; and/or iii. foraminal stenosis, as demonstrated by MRI and/or CT. b. Clinically: radicular symptoms (at least one): i. arm/shoulder pain; ii. decreased reflexes; iii. decreased strength; and/or iv. decreased sensation.

2. Subject has dynamic stenosis relieved by traction and made worse by a Spurlings maneuver.

3. Subject is 35-80 years of age, inclusive.

4. Subject is unresponsive to 6 weeks conservative, nonoperative treatment, or clinically indicated sooner due to the presence of progressive symptoms or signs of nerve root in spite of combined nonoperative management.

5. Preoperative Neck Disability Index (NDI) score of > 30.

6. Preoperative Neck pain or Arm pain score of > 6 on Neck and Arm VAS Pain Scales.

7. Subject is a male or non-pregnant, non-lactating female.

8. Subject must have the ability to understand and voluntarily provide written, informed consent.

9. Subject is able to meet the proposed follow-up schedule.

10. Subject is able to follow the postoperative management program.

Exclusion Criteria:

1. Any previous cervical spinal surgery.

2. Subject has known osteoporosis, osteomalacia, spinal metastases, or metabolic bone disease OR subject has sustained a vertebral compression or nontraumatic hip or wrist fracture.

3. Subject has overt or active spinal and/or systemic infection.

4. Subject has cervical spondylolisthesis > 3.5mm or rotator subluxation.

5. Subject has cervical myelopathy.

6. Subject has a chronic pain syndrome.

7. Subject has radicular findings with major motor impairment.

8. Subject has a condition that requires postoperative medications that interfere with fusion or the stability of the implant, such as steroids (ie. corticosteroids, methotrexate, immunosuppressives).

9. Subject is mentally incompetent.

10. Subject is a prisoner.

11. Subject is pregnant.

12. Subject abuses alcohol or drugs.

13. Subject has a cervical spinal condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level.

14. Subject has insulin dependent diabetes.

15. Subject has chronic or acute renal failure or prior history of renal disease.

16. Subject has documented allergy or intolerance to stainless steel, titanium, or a titanium alloy.

17. Subject has or is planning to receive drugs which may interfere with bone metabolism within two weeks prior to or six months following the date of surgery.

18. Subject has history of an endocrine or metabolic disorder known to affect osteogenesis.

19. Subject has had treatment with an investigational therapy within 28 days prior to surgery or such treatment is planned during the 16 weeks following implantation of DTRAX Cervical Cage with DTRAX Bone Screw.

20. Subject is involved in or planning spinal litigation or Workmen's Compensation claim.

21. Subject is morbidly obese, defined as body mass index (BMI) > 40.

22. Subject has a medical condition or extenuating circumstance that, in the Investigator's opinion, would prevent the subject from complying with postoperative follow-up visits.

Related Conditions & MeSH terms

• Cervical Radiculopathy
• Radiculopathy

Intervention

Device:
• DTRAX® Cervical Cage with DTRAX Bone Screw
DTRAX Cervical Cage is an intervertebral fusion device that provides mechanical support to the spine. DTRAX Cervical Cage is intended to be used in cervical spine fusion surgery. DTRAX Bone Screw is indicated for use in arthrodesis and provides supplemental fixation. .

Locations

Country	Name	City	State
United States	Cary Orthopaedic Spine Specialists	Cary	North Carolina
United States	Daytona Orthopaedic and Spinal Research Group	Daytona Beach	Florida
United States	Upstate Orthopedics	East Syracuse	New York
United States	Southern New York NeuroSurgical Group, P.C.	Johnson City	New York
United States	Louisiana State University Health Sciences Center - New Orleans (LSUHSC - NO)	New Orleans	Louisiana
United States	Neurospine Institute Medical Group	San Francisco	California
United States	Foundation for Orthopaedic Research and Education	Tampa	Florida

Sponsors (1)

Lead Sponsor	Collaborator
Providence Medical Technology, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assess the radiographic outcome data on fusion status, device retention, and maintenance of segmental lordosis at the index level utilizing DTRAX Cervical Cage with DTRAX Bone Screw used in the treatment of cervical radiculopathy		Baseline throughout 24 months post-operatively
Secondary	Assess the clinical outcome data based Neck Disability Index (NDI)		Baseline throughout 24 months post-operatively
Secondary	Assess the clinical outcome data based SF-12 v2 Health Survey		Baseline throughout 24 months post-operatively
Secondary	Assess the clinical outcome data based the Visual Analogue Scale (Neck and Arm VAS)		Baseline throughout 24 months post-operatively
Secondary	Safety information will be evaluated by collecting the type, frequency, severity, and device and procedure-relatedness of adverse events		Baseline throughout 24 months post-operatively